The Statin Scam Exposed by Dr. Malhotra
Dr. Malhotra on the Joe Rogan Experience talks Statins and Vaccines and more
Another example of the crimes committed against the populace by the Big Pharma Cabal. Dr. Aseem Malhotra, the Cardiologist of Vaccine resistance fame was on the Joe Rogan experience. The full interview is below on Spotify, but this clip is about the use of Statins, which millions of peoples around the world are dependent on.
We were told based on one study from decades ago that Statins were the way to go. The Framingham Heart Study from 1948 is what set the standard that is still being practiced today.
The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study that began in 1948 in the town of Framingham, Massachusetts. The study aimed to identify risk factors for heart disease by following the health and lifestyle of thousands of participants over several decades.
The Framingham Heart Study conducted research on the use of statins for the prevention of cardiovascular disease. Statins are a class of drugs used to lower cholesterol levels in the blood, and are commonly prescribed for people at high risk of heart disease.
The study enrolled over 5,000 participants from the town of Framingham, MA and has since expanded to include their children, grandchildren, and even some great-grandchildren. Participants were regularly examined and monitored for various cardiovascular risk factors, including blood pressure, cholesterol levels, smoking status, and other health behaviors.
The Framingham Heart Study has produced numerous important findings, including the identification of risk factors such as high blood pressure, high cholesterol, smoking, and obesity that contribute to heart disease. The study has also contributed to the development of several widely used cardiovascular disease risk prediction models.
Even though, the study is ongoing, why change the rules of the games when it is so highly profitable? Answer, no need to change anything and upset the $$$ gravy train. According to a report published by the IQVIA Institute for Human Data Science in 2018, the total revenue for cholesterol-lowering medications, including Statins, in the United States was approximately $18.7 billion in 2017. The report also noted that statins accounted for the majority of these sales, with Atorvastatin (Lipitor) and Rosuvastatin (Crestor) being the top two selling Statins.
And overall American medicine spending is expected to increase 3-6 percent on net basis to $420 billion by 2023. A more recent report, cites the growing use of Statins and no slow down in sales are projected. Business is booming in this little segment.
New York, March 02, 2023 (GLOBE NEWSWIRE) -- The global statins market size reached US$ 15 Billion in 2021 and the global Statins Market is projected to reach US$ 22 Billion by 2032. The global market for statins is estimated to expand at a CAGR of 3.5% during the forecast period. Increasing incidence of high cholesterol & obesity is expected to drive the global statins market. North America enjoys the biggest share in the global statins market, with the U.S. leading the way.
Just how big was the financial swindle? Answer, according to Dr. Malhotra over a five-year period, taking a Statin religiously and not getting side effects adds just over 4 days to your life expectancy.
Does that qualify as a Bank Robbery or just as a Scam? Because who knew going to the Doctors’ office was the fastest way to lose both your health and your wealth? Answer, only alternative news sites such as this one will tell you the real ugly truths, because no Doctor other than the few Outliers mentioned here will ever let you the truth and cut off the hand that feeds them.
That's right a grand total of 4 days, while the Big Pharma Cabal made how much? Answer, Billions and Billions were raked in. Was adding 4 days to your life and it costing your thousands worth the cost and trouble? Answer, probably not. Better results could have been achieved by lifestyle changes. Walking more, eating less, and reducing sources of inflammation such as the cooking oils you use and avoiding seed oils such as canola and corn oil would have done more for you than those Statin pills.
In this BMJ an opinion piece or editorial, Dr. Malhotra argues that coronary heart disease (CHD) is a chronic inflammatory condition that can be effectively reduced through lifestyle interventions, including changes in diet and exercise. The authors dispute the widely held belief that saturated fat intake is a major contributor to CHD, and instead point to other factors such as stress, poor sleep, and lack of physical activity as key drivers of the disease. He argues that lifestyle interventions should be the primary approach to reducing the risk of CHD, rather than Statins medications.
For Doctors and the Big Pharma Cabal you are not a Patient, but rather a unique Billing Reference Account Number. Milk that Account for as long as possible and then move on to the next Victim’s Account. Notice Doctors never cure ailments now. Their primary function as the willing minions of the the Big Pharma Cabal is to provide you with "symptom management options", aka an endless vicious cycle of prescription Pills and Doctors visits.
As in how to get you back for another Appointment and another Prescription for the Drugs that do more harm in terms of side effects than have any use to on your overall health outcomes. A wide generalization Yes, but the more studies that are done the more this trend is confirmed. After decades of promoting the daily use of Aspirin, we are now told well there might be a problem here.
This randomized, double-blind, placebo-controlled trial conducted in Australia found that daily low-dose aspirin use in healthy elderly individuals did not significantly reduce the risk of cardiovascular disease or dementia, but did increase the risk of major bleeding events.
And this meta-analysis of randomized controlled trials found that while aspirin use was associated with a reduced risk of non-fatal heart attack and non-fatal stroke, it did not significantly reduce the risk of death from cardiovascular causes or all-cause mortality.
This meta-analysis of randomized controlled trials found that aspirin use for primary prevention of cardiovascular events did not significantly reduce the risk of major adverse cardiovascular events or all-cause mortality in the overall population, and subgroup analyses suggested that it may not be effective in certain subgroups, such as women and individuals with diabetes.
An important Disclaimer, we are not offering medical advice and it's important to note that these studies represent a range of viewpoints on the use of aspirin and that the benefits and risks of aspirin use can vary depending on an individual's health status and other factors. As with any medication, it's important to discuss the potential benefits and risks of aspirin use with a healthcare provider.
But did that stop Doctors from auto prescribing such drugs like they were handing out candy to little children? Answer, no because there too much money to be lost in rocking the boat. What has been programmed into the mind of Patients will remain in place and millions will continue to believe their only option for health and well-being lies in the Doctors office and the Pills he prescribes. The quest for “ethical evidence-based medical practice” continues, so until then be alert and vigilant to the big game.
A Summary of the JRE clip below for further reference. What was Lesson to be learnt here? Answer, be very careful from whom to get your information from especially when at the Doctors office.
Cardiologist on the Over-Prescribing of Statins for Heart Disease
00:00 Understanding Cholesterol and Heart Disease
Section Overview: In this section, the speaker discusses the association between cholesterol and heart disease, as well as how statins work to lower cholesterol.
The Association Between Cholesterol and Heart Disease
00:23 The association of high cholesterol with heart disease came from the Framingham study in Massachusetts.
01:03 Total cholesterol is not a good indicator of heart disease risk. Most of your cholesterol is genetic, and people with genetically low cholesterol tend to not develop premature heart disease.
01:51 Once you hit 50, as your cholesterol drops in Framingham, your mortality rate increases.
How Statins Work to Lower Cholesterol
03:02 LDL bad cholesterol has no value in isolation in predicting heart disease.
03:41 Randomized control trial data shows that there is no clear correlation between lowering LDL cholesterol and preventing heart attacks and strokes.
04:36 Statins: Are the Benefits Overstated?
Section Overview: In this section, Dr. Aseem Malhotra discusses the benefits of statins in preventing heart attacks and strokes.
Benefits of Statins
Statins have anti-inflammatory and anti-clotting benefits.
The real benefit in preventing heart attacks and strokes is through these mechanisms.
The benefits are about 1% if you're low risk of heart disease.
If you've had a heart attack, the benefit of a statin is 1 in 83 for saving your life and 1 in 39 for preventing a further heart attack over a five-year period.
04:53 Prescribing Statins After Heart Attacks
Section Overview: In this section, Dr. Aseem Malhotra talks about prescribing statins after heart attacks.
Prescribing Statins
Many patients who have had heart attacks are automatically put on statins.
Cardiologists read even checked their cholesterol because in the Cardiology Community they kind of knew that was like it doesn't matter what your cholesterol is let's put them on a Statin because the trials show there are benefits.
Patients should be informed about the benefits before taking statins to avoid an exaggerated fear of stopping or an illusion of protection.
05:04 Absolute Terms
Section Overview: In this section, Dr. Aseem Malhotra explains the absolute terms when breaking down the benefits of statins.
Breaking Down Benefits
When breaking down the benefits in absolute terms, it's important to note that best case scenario your benefit of a Statin is 1 in 83 for saving your life right and 1 in 39 and preventing a further heart attack over a five-year period.
People find these numbers underwhelming.
05:19 Statin Benefits in Populations
Section Overview: In this section, Dr. Aseem Malhotra talks about the benefits of statins in populations.
Looking at Statistics
An average person who has had a heart attack and takes statins for five years would add just over four days to their life expectancy.
There's an assumption that mass prescription of statins has driven down death rates from heart disease, but the evidence suggests otherwise.
In European countries high risk and low-risk people of heart disease over 12 years was there a difference in was there a reduction in heart disease death rates because of statins and the answer was no.
05:36 Stopping Statin Use
Section Overview: In this section, Dr. Aseem Malhotra talks about stopping statin use.
Side Effects
Real-world data tells us that even people who have had heart attacks may stop taking statins within a few years mainly because of side effects.
About 50% of them will stop taking it.
This hasn't had an impact on the population.
07:28 Reaction to Publication
Section Overview: In this section, Dr. Aseem Malhotra talks about the reaction to his publication on the benefits of statins.
Publication Reaction
After his publication in BMJ initially um and then he lost his job.
The benefits of statins are marginal despite being one of the most powerful lucrative drugs in the history of medicine.
09:01 Working for Free in a Cardiology Department
Section Overview: In this section, Dr. Aseem Malhotra discusses his experience working for free in a Cardiology Department and how he received an email from the editor of the British Medical Journal.
Email from the Editor of the British Medical Journal
09:01 Dr. Aseem Malhotra received an email from the editor of the British Medical Journal asking to meet with him.
The editor informed Dr. Aseem Malhotra about Professor Rory Collins, who is considered one of the world's leading Statin researchers at Oxford University.
Professor Rory Collins had requested that Abramson and Malhotra's papers be retracted due to significant errors on the side effect issue.
Back and Forth with BMJ
09:42 The BMJ refused to retract Abramson and Malhotra's papers but offered to publish a critique if Dr. Aseem Malhotra wanted to send one.
However, Professor Rory Collins decided not to do so and instead went to The Guardian newspaper with his concerns.
This caused a lot of backlash as people were concerned that it would cause harm since patients would stop taking their statins.
10:19 Potential Career Destruction
Section Overview: In this section, Dr. Aseem Malhotra talks about how he was essentially on trial for two months due to potential career destruction after articles were sent for independent review by BMJ.
Independent Review by BMJ
10:19 Articles were sent for independent review by BMJ which could have potentially destroyed Dr. Aseem Malhotra’s career if they were retracted.
The panel convened and asked Dr. Aseem Malhotra to send in responses before coming back 6-0 unanimous in favor of not retracting his article.
Continuing Campaign
After this experience, Dr. Aseem Malhotra continued his campaign on ethical evidence-based medical practice and published other journals.
He talked about transparent communication, ethical evidence-based medicine, and the prescription of statins.
Dr. Aseem Malhotra also discussed how focusing on lifestyle changes such as low carb Mediterranean diet and exercise could be more powerful than just giving people pills.
12:49 Backlash
Section Overview: In this section, Dr. Aseem Malhotra talks about the backlash he faced during his campaign.
Developing a Thick Skin
12:33 Dr. Aseem Malhotra realized that as a public health advocate, he needed to have a thick skin and grow a rhinoceros hyde due to the backlash he faced.
There was smearing going on but Dr. Aseem Malhotra continued his campaign for ethical evidence-based medical practice.
Interesting Journey
The journey was interesting as there were many challenges along the way.
However, Dr. Aseem Malhotra continued to push forward with his campaign despite the potential career destruction and backlash he faced.
13:31 The Importance of Truth and Transparency in Medicine
Section Overview: In this section, the speaker talks about how speaking out against corruption and conflicts of interest in medicine can lead to attacks, but it is important to stand up for truth and transparency.
Standing Up Against Industry Threats
13:31 When your work threatens an industry or an ideological cabal, you will be attacked.
13:50 Other doctors came out to support the speaker when they spoke out against corruption and conflicts of interest in medicine.
14:11 The speaker believes that there are biases and conflicts of interest in the research on statins coming from a department at Oxford that has taken over 200 million pounds from the drug industry.
14:27 The data from the department was kept commercially confidential, making it impossible for anyone to independently verify the data.
Conflicts of Interest Limiting Judgment
14:44 Professor Collins' judgment may be clouded by his conflict of interest as his department has received funding from the drug industry for research on statins.
The speaker believes that Professor Collins' lack of clinical experience limits his ability to properly evaluate evidence.
Endure till the End and take Care of Yourself. Remember on planes they always tell you put the mask on first, before helping others. Therefore, Take Care of Yourself First and then do what is in your control, and then leave the rest to the universe to solve.
We are 100 Percent Independent and Supported by Readers and Viewers like YOU! Digital Hugs appreciated and Subscribers are even more deeply appreciated.
Until we meet again.
For we wrestle not against flesh and blood, but against principalities, against powers, against the rulers of the darkness of this world, against spiritual wickedness in high places.
Ephesians 6:12
- Corona Times News
FAIR USE NOTICE
The views expressed by guests, subjects and speakers are their own and their appearance on this website does not imply if any way an endorsement of them or any entity they represent. Views and opinions expressed by the speakers do not necessarily reflect the views of Corona Times News. THIS CONSTITUTES A 'FAIR USE' OF ANY SUCH MATERIAL AS PROVIDED FOR PURSUANT TO TITLE 17 UNITED STATES CODE SECTION 106A-117 REGARDING USE OF COPYRIGHT MATERIAL.
DISCLAIMER
The content provided on The Corona Times News is for general information and entertainment purposes only. No information, materials, services, and other content provided in this post constitutes solicitation, recommendation, endorsement or any financial, investment, medical, health, educational, or other advice. Seek independent professional consultation in the form of legal, financial, and fiscal advice before making any investment decisions. Always perform your own due diligence. And don't forget to have a wonderful day.